AbCellera Biologics(ABCL) - 2024 Q2 - Earnings Call Presentation

AbCellera 42 2024 BUSINESS UPDATE AUGUST 6, 2024 DISCLAIMER 2024 BUSINESS UPDAT This presentation contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are based on management's beliefs and assumptions and on information currently available to management. All statements contained in this presentation other than statements of historical fact are forward-looking statements, i ...